Cardioprotective effect of epigallocatechin-3-gallate against myocardial infarction in hypercholesterolemic rats Retraction in /10.3892/etm.2024.12396

Zhong,Wei; Huan,Xiao‑Dong; Cao,Qian; Yang,Jun

doi:10.3892/etm.2014.2135

Cardioprotective effect of epigallocatechin-3-gallate against myocardial infarction in hypercholesterolemic rats

Retraction in: /10.3892/etm.2024.12396

Authors:
- Wei Zhong
- Xiao‑Dong Huan
- Qian Cao
- Jun Yang
View Affiliations

Affiliations: Cadre Ward, Zaozhuang Municipal Hospital, Zaozhuang, Shandong 277101, P.R. China, Department of Cardiology, Zaozhuang Hospital of Traditional Chinese Medicine, Zaozhuang, Shandong 277300, P.R. China, Department of Cardiology, Zaozhuang Municipal Hospital, Zaozhuang, Shandong 277101, P.R. China
Published online on: December 16, 2014 https://doi.org/10.3892/etm.2014.2135
Pages: 405-410

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Cardiovascular diseases are closely associated with a high‑cholesterol or high‑fat diet. The aim of the present study was to investigate the cadioprotective effect of epigallocatechin‑3‑gallate (EGCG) in high‑fat diet‑fed rats, with special emphasis on myocardial infarction. a high‑fat diet was administered to male wistar rats for 45 days and the rats of the treatment group were administered EGCG via intraperitoneal injection for the last 15 days. The serum lipid profile, antioxidant enzyme activity, lipid peroxidation, lipid metabolic proteins and cardiac tissue markers were assessed. The myocardium and aorta were also histopathologically examined. The high‑fat diet‑fed rats were found to be hypercholesterolemic or exhibited abnormal values in the selected parameters. However, these abnormalities were reversed to near‑normal values in the rats administered EGCG. Similarly, the enzymatic antioxidant activity and non‑enzymatic antioxidant levels were improved with EGCG treatment in high‑fat diet‑fed rats. In addition, EGCG activated sirtuin 1, endothelial nitric oxide synthase and AMP-activated protein kinase α, which suggests that its protective effect is mediated through the stimulation of lipid metabolism. The histopathological examination further revealed that EGCG significantly prevented the development of tissue abnormalities and improved the morphology of myocardial tissue. Taken together, our results suggested that EGCG plays a significant role in the protection of the cardiovascular system against the high‑fat diet. This is a preliminary study, emphasizing on the cardioprotective properties of EGCG. we are currently analyzing the molecular mechanism underlying the protective effects of EGCG.

View Figures

View References

1	Ferrières J: The French paradox: lessons for other countries. Heart. 90:107–111. 2004. View Article : Google Scholar
2	Walker AF: Of hearts and herbs. Biologist. 43:177–180. 1996.
3	Frankel EN, Waterhouse AL and Teissedre PL: Principal phenolic phytochemicals in selected Californian wines and their antioxidant activity in inhibiting oxidation of human low-density lipoproteins. J Agric Food Chem. 43:890–894. 1995. View Article : Google Scholar
4	Vinson JA, Teufel K and Wu N: Green and black teas inhibit atherosclerosis by lipid, antioxidant, and fibrinolytic mechanisms. J Agric Food Chem. 52:3661–3665. 2004. View Article : Google Scholar : PubMed/NCBI
5	Aviram M and Eias K: Dietary olive oil reduces the susceptibility of low-density lipoprotein to lipid peroxidation and inhibits lipoprotein uptake by macrophages. Ann Nutr Metab. 37:75–84. 1993. View Article : Google Scholar
6	Stangl V, Dreger H, Stangl K and Lorenz M: Molecular targets of tea polyphenols in the cardiovascular system. Cardiovasc Res. 73:348–358. 2007. View Article : Google Scholar
7	Chan K, Lu R, et al: NRF2, a member of the NFE2 family of transcription factors, is not essential for murine erythropoiesis, growth, and development. Proc Natl Acad Sci USA. 93:13943–13948. 1996. View Article : Google Scholar : PubMed/NCBI
8	Araujo JA, Barajas B, Kleinman M, et al: Ambient particulate pollutants in the ultrafine range promote early atherosclerosis and systemic oxidative stress. Circ Res. 102:589–596. 2008. View Article : Google Scholar : PubMed/NCBI
9	Duarte MM, Rocha JB, Moresco RN, et al: Association between ischemia-modified albumin, lipids and inflammation biomarkers in patients with hypercholesterolemia. Clin Biochem. 42:666–671. 2009. View Article : Google Scholar : PubMed/NCBI
10	Quist EE: Regulation of erythrocyte membrane shape by Ca²⁺. Biochem Biophys Res Commun. 92:631–637. 1980. View Article : Google Scholar : PubMed/NCBI
11	Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 72:248–254. 1976. View Article : Google Scholar : PubMed/NCBI
12	Ohkawa H, Ohishi N and Yagi K: Assay of lipid peroxides in animal tissue by thiobarbituric acid reaction. Anal Biochem. 95:351–358. 1979. View Article : Google Scholar : PubMed/NCBI
13	Sinha AK: Colorimetric assay of catalase. Anal Biochem. 47:389–394. 1972. View Article : Google Scholar : PubMed/NCBI
14	Marklund S and Marklund G: Involvement of the superoxide anion radical in the autooxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem. 47:469–474. 1974. View Article : Google Scholar : PubMed/NCBI
15	Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG and Hoekstra WG: Selenium: biochemical role as a component of glutathione peroxidase. Science. 179:588–590. 1973. View Article : Google Scholar : PubMed/NCBI
16	Moron MS, Depierre JW and Mannervik B: Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochim Biophys Acta. 582:67–78. 1979. View Article : Google Scholar : PubMed/NCBI
17	Omaye ST, Turnbull JD and Sauberlich HE: Selected methods for the determination of ascorbic acid in animal cells, tissues, and fluids. Methods Enzymol. 62:3–11. 1979. View Article : Google Scholar : PubMed/NCBI
18	Desai ID: Vitamin E analysis methods for animal tissues. Methods Enzymol. 105:138–147. 1984. View Article : Google Scholar : PubMed/NCBI
19	King J: The dehydrogenases or oxidoreductases - lactate dehydrogenase. Practical Clinical Enzymology. Van Nostrand Company Ltd; London: pp. 83–93. 1965
20	Hodis HN, Crawford DW and Sevanian A: Cholesterol feeding increases plasma and aortic tissue cholesterol oxide levels in parallel: further evidence for the role of cholesterol oxidation in atherosclerosis. Atherosclerosis. 89:117–126. 1991. View Article : Google Scholar : PubMed/NCBI
21	Brown MS, Ho YK and Goldstein JL: The cholesterol ester cycle in macrophage foam cells. J Biol Chem. 225:9344–9352. 1980.
22	Applebaum BD, Haffner SM, Hartsook E, Luk KH, Albers JJ and Hazzard WR: Down-regulation of the low-density lipoprotein receptor by dietary cholesterol. Am J Clin Nutr. 39:360–367. 1984.
23	Yu YM, Chang WC, Wu CH and Chiang SY: Reduction of oxidative stress and apoptosis in hyperlipidemic rabbits by ellagic acid. J Nutr Biochem. 16:675–681. 2005. View Article : Google Scholar : PubMed/NCBI
24	Lee MK, Park YB, Moon SS, et al: Hypocholesterolemic and antioxidant properties of 3-(4-hydroxyl) propanoic acid derivatives in high-cholesterol fed rats. Chem Biol Interact. 170:9–19. 2007. View Article : Google Scholar : PubMed/NCBI
25	Gökkusu C, Ademoğlu E, Türkoğlu UM, Oz H and Oz F: Thymosin alpha 1 protects liver and aorta from oxidative damage in atherosclerotic rabbits. Life Sci. 59:1059–1067. 1996. View Article : Google Scholar : PubMed/NCBI
26	Dayanandan A, Kumar P and Panneerselvam C: Protective role of L-carnitine on liver and heart lipid peroxidation in atherosclerotic rats. J Nutr Biochem. 12:254–257. 2001. View Article : Google Scholar : PubMed/NCBI
27	Thiruchenduran M, Vijayan NA, Sawaminathan JK and Devaraj SN: Protective effectof grape seed proanthocyanidins against cholesterol cholic acid diet-induced hypercholesterolemia in rats. Cardiovasc Pathol. 20:361–368. 2011. View Article : Google Scholar
28	Agar NS, Sadrzadeh SM, Hallaway PE and Eaton JW: Erythrocyte catalase. A somatic oxidant defense? J Clin. 77:319–321. 1986.
29	Sudhahar V, Ashok Kumar S and Varalakshmi P: Role of lupeol and lupeol linoleate on lipemic-oxidative stress in experimental hypercholesterolemia. Life Sci. 78:1329–1335. 2006. View Article : Google Scholar
30	Wang WF, Luo J, et al: Interaction of phenolic antioxidants and hydroxyl radicals. Radiat Phys Chem. 42:985–987. 1993. View Article : Google Scholar
31	Stein S and Matter CM: Protective roles of SIRT1 in atherosclerosi. Cell Cycle. 10:640–647. 2011. View Article : Google Scholar : PubMed/NCBI
32	Steinberg GR and Kemp BE: AMPK in health and disease. Physiol Rev. 89:1025–1078. 2009. View Article : Google Scholar : PubMed/NCBI
33	Misra P: AMP activated protein kinase; a next generation target for total metabolic control. Expert Opin Ther Targets. 12:91–100. 2008.
34	Mitani H, Egashira K and Kimura M: HMG-CoA reductase inhibitor, fluvastatin, has cholesterol-lowering independent ‘direct’ effects on atherosclerotic vessels in high cholesterol diet-fed rabbits. Pharmacol Res. 48:417–427. 2003. View Article : Google Scholar : PubMed/NCBI
35	Turan B, Tuncay E and Vassort G: Resveratrol and diabetic cardiac function: focus on recent in vitro and in vivo studies. J Bioenerg Biomembr. 44:281–296. 2012. View Article : Google Scholar : PubMed/NCBI